Vanderbilt joins Wellcome Leap global network dedicated to accelerating breakthroughs in human health
Jan. 28, 2021—Vanderbilt University has joined the Leap Health Breakthrough Network, a global group of leading academic and research institutions committed to solving the world’s most serious health challenges.
Sep. 30, 2020—The Faculty Senate, in partnership with Vice Provost for Faculty Affairs Tracey George and Vice Provost for Research Padma Raghavan, will host a series of workshops for faculty outlining the ways the new Vanderbilt Strong Faculty Grant Program can be used.
Sep. 9, 2020—The university’s transition to the new Vanderbilt Electronic Research Administration system, provided by Huron, recently entered the iterations phase of its implementation timeline after concluding the configuration phase, which took place from May to July.
Assistant director of NSF’s Computer and Information Science and Engineering to give virtual talk Sept. 11
Sep. 3, 2020—Margaret Martonosi, assistant director of Computer and Information Science and Engineering at the National Science Foundation, will speak at a virtual campus visit on Friday, Sept. 11, from 2 to 4 p.m. CT.
Aug. 7, 2020—The Vanderbilt Faculty Senate and Vice Provost for Research Padma Raghavan will co-host a virtual town hall on Tuesday, Aug. 11, to discuss the progress of the new Vanderbilt Electronic Research Administration (VERA) system and its implications for university research.
Jul. 23, 2020—VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease.
Center for Technology Transfer & Commercialization breaks records in rapid facilitation of COVID-19 related agreements
Jul. 9, 2020—To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time.
Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders
Jun. 16, 2020—Vanderbilt University’s Warren Center for Neuroscience Drug Discovery has entered into an exclusive worldwide licensing and collaboration agreement with San Diego-based ACADIA Pharmaceuticals Inc. to develop treatments for disorders like Alzheimer’s and schizophrenia.
May. 22, 2020—In this month’s edition of the "Open Dore" newsletter, Vice Provost for Research Padma Raghavan discusses how the research community has continued to innovate during the COVID-19 pandemic, and how it's leading the way as Vanderbilt ramps up its Return to Campus Plan.
May. 9, 2020—
New COVID-19 Research and Innovation Fund engages community in Vanderbilt’s fight against coronavirus
Apr. 29, 2020—Vanderbilt University has established a new COVID-19 Research and Innovation Fund. The fund enables donations to support research and innovation projects to fight COVID-19.
Apr. 27, 2020—After more than a year of vendor comparison and implementation preparation, Vanderbilt University has selected Huron Grants and Agreements to replace Vanderbilt’s current electronic research administration systems, Coeus and PEER.